About
Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. The company offers its products in various dosage forms, including tablets, capsules, and solid orals. It provides various products for cardiovascular and hypertension, potent oncology, anti-infectives, central nervous system, and diabetic related diseases, as well as provision of contract research and manufacturing services. It also exports its products to Europe, the United Kingdom, Australia, Sri Lanka, Africa, Philippines, Tanzania, and Nigeria. Bafna Pharmaceuticals Limited was founded in 1981 and is based in Chennai, India. The company operates as a subsidiary of SRJR Lifesciences LLP.
Key Metrics
as of Sep 2026Market Cap700 Cr
P/E—
Div Yield0.00 %
Book Value₹216.00
52w High₹318.00
52w Low₹94.80
Face Value₹10.00
Quarterly Results
Rs. Crores · hover row for definition| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 26.58 | 42.24 | 38.29 | 35.47 | 34.62 | 39.06 | 33.19 | 40.32 | 33.29 | 41.40 | 28.44 | 40.68 | 41.95 |
| Expenses | 25.69 | 38.69 | 35.24 | 31.19 | 29.55 | 35.95 | 30.13 | 36.53 | 32.08 | 38.51 | 30.51 | 36.67 | 35.66 |
| Operating Profit | 0.89 | 3.55 | 3.05 | 4.28 | 5.07 | 3.11 | 3.06 | 3.79 | 1.21 | 2.89 | -2.07 | 4.01 | 6.29 |
| OPM % | 3.35 | 8.40 | 7.97 | 12.07 | 14.64 | 7.96 | 9.22 | 9.40 | 3.63 | 6.98 | -7.28 | 9.86 | 14.99 |
| Other Income | 1.91 | 1.76 | 1.22 | 1.18 | 0.60 | -0.76 | 0.18 | 1.02 | 0.16 | 0.52 | 0.98 | 0.16 | 1.87 |
| Depreciation | 1.78 | 1.66 | 1.57 | 1.47 | 1.37 | 0.22 | 1.66 | 1.58 | 1.44 | 1.27 | 1.27 | 1.24 | 1.21 |
| Interest | 0.94 | 1.03 | 0.86 | 0.86 | 0.91 | 0.82 | 0.64 | 0.62 | 0.65 | 0.68 | 0.58 | 0.44 | 0.60 |
| Profit before tax | 0.08 | 2.62 | 1.84 | 3.13 | 3.39 | 1.31 | 0.94 | 2.61 | -0.72 | 1.46 | -2.94 | 2.49 | 6.35 |
| Tax % | 0.00 | -4.96 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit | 0.08 | 2.75 | 1.84 | 3.12 | 3.39 | 1.31 | 0.95 | 2.62 | -0.72 | 1.46 | -2.94 | 2.48 | 6.35 |
| EPS in Rs | 0.03 | 1.16 | 0.78 | 1.32 | 1.43 | 0.55 | 0.40 | 1.11 | -0.30 | 0.62 | -1.24 | 1.05 | 2.68 |
Profit & Loss
Annual · Rs. Crores| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 151.00 | 146.00 | 152.00 | 115.00 | 85.00 | 71.00 | 42.00 | 44.00 | 46.00 | 65.00 | 85.00 | 100.00 |
| Expenses | 135.00 | 135.00 | 141.00 | 100.00 | 73.00 | 61.00 | 41.00 | 57.00 | 81.00 | 70.00 | 82.00 | 116.00 |
| Operating Profit | 16.00 | 11.00 | 11.00 | 16.00 | 12.00 | 10.00 | 1.00 | -13.00 | -35.00 | -5.00 | 3.00 | -16.00 |
| OPM % | 11.00 | 8.00 | 7.00 | 14.00 | 14.00 | 14.00 | 2.90 | -30.00 | -77.00 | -8.00 | 3.30 | -16.00 |
| Other Income | 5.00 | 1.00 | 4.00 | 3.00 | 0.00 | 1.00 | -23.00 | 0.00 | 31.00 | 1.00 | 1.00 | 40.00 |
| Interest | 4.00 | 3.00 | 2.00 | 2.00 | 1.00 | 1.00 | 0.00 | 2.00 | 7.00 | 11.00 | 12.00 | 12.00 |
| Depreciation | 6.00 | 5.00 | 5.00 | 5.00 | 5.00 | 4.00 | 3.00 | 3.00 | 4.00 | 4.00 | 4.00 | 5.00 |
| Profit before tax | 11.00 | 4.00 | 7.00 | 12.00 | 5.00 | 6.00 | -25.00 | -18.00 | -14.00 | -19.00 | -13.00 | 6.00 |
| Tax % | -1.00 | 0.00 | 0.00 | 2.00 | 0.00 | 0.00 | 0.00 | 8.00 | 15.00 | -4.00 | -3.00 | 0.00 |
| Net Profit | 11.00 | 4.00 | 7.00 | 11.00 | 5.00 | 6.00 | -25.00 | -20.00 | -16.00 | -18.00 | -12.00 | 6.00 |
| EPS in Rs | 4.69 | 1.75 | 3.11 | 4.79 | 2.21 | 2.46 | -106.53 | -8.34 | -6.95 | -9.90 | -6.53 | 3.28 |
| Dividend Payout % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Balance Sheet
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 2.00 | 24.00 | 24.00 | 19.00 | 19.00 | 19.00 |
| Reserves | 72.00 | 61.00 | 57.00 | 50.00 | 38.00 | 33.00 | 49.00 | -3.00 | 17.00 | 26.00 | 41.00 | 53.00 |
| Borrowings | 37.00 | 28.00 | 24.00 | 23.00 | 11.00 | 15.00 | 3.00 | 46.00 | 47.00 | 82.00 | 80.00 | 64.00 |
| Other Liabilities | 42.00 | 40.00 | 42.00 | 33.00 | 17.00 | 14.00 | 17.00 | 54.00 | 40.00 | 40.00 | 45.00 | 50.00 |
| Total Liabilities | 176.00 | 153.00 | 148.00 | 130.00 | 90.00 | 86.00 | 71.00 | 121.00 | 128.00 | 167.00 | 185.00 | 185.00 |
| Fixed Assets | 82.00 | 59.00 | 40.00 | 40.00 | 39.00 | 36.00 | 35.00 | 37.00 | 40.00 | 43.00 | 47.00 | 49.00 |
| CWIP | 3.00 | 7.00 | 12.00 | 2.00 | 0.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 1.00 | 18.00 | 18.00 | 18.00 |
| Other Assets | 91.00 | 87.00 | 95.00 | 88.00 | 51.00 | 50.00 | 36.00 | 82.00 | 86.00 | 106.00 | 120.00 | 118.00 |
| Total Assets | 176.00 | 153.00 | 148.00 | 130.00 | 90.00 | 86.00 | 71.00 | 121.00 | 128.00 | 167.00 | 185.00 | 185.00 |
Cash Flows
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 15.00 | 22.00 | 9.00 | 5.00 | 10.00 | -14.00 | -34.00 | -1.00 | -7.00 | 14.00 | -3.00 | 9.00 |
| Cash from Investing Activity | -22.00 | -21.00 | -15.00 | -7.00 | -7.00 | -5.00 | 33.00 | 4.00 | 38.00 | -8.00 | -1.00 | 56.00 |
| Cash from Financing Activity | 6.00 | 1.00 | -1.00 | 10.00 | -5.00 | 12.00 | 7.00 | -2.00 | -31.00 | -5.00 | 4.00 | -66.00 |
| Net Cash Flow | -1.00 | 2.00 | -6.00 | 8.00 | -2.00 | -7.00 | 6.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow | -10.00 | 0.00 | -6.00 | -2.00 | 2.00 | -20.00 | -36.00 | -1.00 | 40.00 | 20.00 | -5.00 | 2.00 |
| CFO/OP % | 94.00 | 194.00 | 87.00 | 32.00 | 83.00 | -132.00 | -2,786.00 | 8.00 | 20.00 | -263.00 | -106.00 | -74.00 |
Ratios
Annual · Days / % — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 106.00 | 101.00 | 109.00 | 130.00 | 63.00 | 49.00 | 52.00 | 208.00 | 195.00 | 302.00 | 291.00 | 303.00 |
| Inventory Days | 129.00 | 127.00 | 125.00 | 129.00 | 185.00 | 154.00 | 208.00 | 122.00 | 102.00 | 118.00 | 92.00 | 66.00 |
| Days Payable | 139.00 | 140.00 | 149.00 | 165.00 | 113.00 | 107.00 | 229.00 | 517.00 | 265.00 | 164.00 | 169.00 | 149.00 |
| Cash Conversion Cycle | 96.00 | 88.00 | 84.00 | 94.00 | 135.00 | 96.00 | 31.00 | -188.00 | 31.00 | 255.00 | 214.00 | 220.00 |
| Working Capital Days | 74.00 | 74.00 | 92.00 | 104.00 | 123.00 | 121.00 | 89.00 | -210.00 | -108.00 | -36.00 | 125.00 | 56.00 |
| ROCE % | 12.00 | 8.00 | 9.00 | 16.00 | 11.00 | 10.00 | -3.00 | -21.00 | -35.00 | -6.00 | 0.00 | -13.00 |
Corporate Actions
6 records| Action | Ex Date | Record Date | Ratio | Amount (₹) | Notes |
|---|---|---|---|---|---|
| Other | 17 Sep 2024 | — | — | — | Annual General Meeting |
| Other | 20 Jul 2022 | — | — | — | Annual General Meeting |
| Other | 05 Aug 2021 | — | — | — | Annual General Meeting |
| Other | 23 Jul 2020 | — | — | — | Annual General Meeting |
| Other | 26 Aug 2019 | 27 Aug 2019 | — | — | Reduction of Capital |
| Dividend | 19 Sep 2013 | — | — | 0.60 |
Announcements
5 filingsShareholding Pattern
Open on BSEFinancial Results — Filings
Open on BSEBoard Filings
Open on BSEAnnual Reports
Credit Ratings
-
Rating update23 Jan from icra
-
Rating update2 Apr 2025 from icra
-
Rating update5 Feb 2024 from icra
-
Rating update4 Mar 2020 from crisil
-
Rating update27 Feb 2020 from crisil
-
Rating update29 Jan 2020 from crisil